© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Bosutinib Monohydrate stands out as a well-defined chemical compound, with practical applications in medicine and research. Known for its activity as a tyrosine kinase inhibitor, this material plays a significant role in the treatment of chronic myelogenous leukemia (CML). Unlike generic chemical products, Bosutinib Monohydrate arrives in the lab after a long process of careful raw material selection, purification, and precision synthesis. Every batch brings with it strict standards for consistency, purity, and traceability—this is a must when working with medicines that target life-threatening diseases. Manufacturers track everything down to the lot number, as any misstep could compromise both safety and effectiveness.
Bosutinib Monohydrate holds the molecular formula C26H29Cl2N5O3·H2O, with a molar mass around 556.47 g/mol when accounting for the monohydrate form. Chemically, it features a pyrimidine core with chlorinated and morpholinyl functional groups. As a solid, most suppliers deliver the compound as an off-white to pale-yellow crystalline powder. Each crystal, though microscopic, offers a window into the material's stability, storability, and proper handling. Density commonly measures around 1.6 g/cm³. The tiny flakes sometimes form aggregates, but don't expect to see anything resembling large pearls or dissolved solution under normal storage conditions. This product does not occur as a liquid or syrup under everyday room temperature and pressure, and it definitely doesn't resemble commercial pearls or granules.
Every shipment of Bosutinib Monohydrate usually arrives sealed in airtight packaging and protected from light to preserve quality. The solid comes as fine crystals or powder, making weighing and aliquoting feasible for small-scale research or clinical usage. Particulate size may shift a bit between suppliers, though key specs—such as water content, identifiable by Karl Fischer titration, and purity, confirmed by HPLC or NMR analysis—need rigorous confirmation. Density doesn't drift much from batch to batch, a welcome point for those measuring bulk mass for solution preparation.
International trade handles Bosutinib Monohydrate under HS Code 2934999099. Appropriate labeling on all documentation guarantees that the compound crosses borders with full transparency. Anyone importing or exporting must declare the correct code to regulatory authorities, ensuring both customs compliance and easy tracking for pharmacovigilance and chemical safety records.
People handling Bosutinib Monohydrate need to respect its classification as a hazardous chemical. The compound may pose harm through inhalation, ingestion, or skin contact. Labels highlight dangers of acute toxicity, environmental hazard, and health effects with the necessary pictograms. In professional practice, gloves, goggles, and lab coats minimize exposure for handlers, and dedicated fume hoods or proper ventilation remain non-negotiable. Spills demand immediate containment—according to experience, even a small release of pharmaceutical powder makes its presence known by odor or taste before analytical equipment picks it up. As a controlled pharmaceutical, unqualified users do not handle this compound. Waste returns to purpose-built containers, later treated as hazardous chemical waste under local and international standards.
Bosutinib Monohydrate serves a targeted purpose in cancer treatment, and every decision about its structure impacts downstream efficacy. Solid-state properties influence how the drug dissolves and distributes in the body, setting it apart from generic ingredients in the chemical supply chain. In my experience with pharmaceutical laboratories, the transition from pure compound to finished drug product hinges on reliable detection and quantification—material that fails to meet established density, water content, or appearance criteria simply gets scrapped to protect patient safety. Researchers track trace impurities for each batch with LC-MS, because unknown side-products can affect results or safety.
Dealing with Bosutinib Monohydrate means treating every gram with the seriousness it deserves—this isn’t bulk commodity chemical, but a tightly regulated therapeutic material. Its specific physical properties, tightly defined chemical structure, and high purity drive both research and patient outcomes. Handling hazards, strict compliance with HS code, precise documentation, and attention to detail define day-to-day work with this compound. Supporting the entire supply chain—down to the raw materials—demands trust in suppliers, keen oversight, and unwavering respect for safety rules. Anyone in the field knows that even with standard operation procedures in place, vigilance remains the key to safe, responsible, and effective use of this material.
